Barbara Camilloni
Perugia, 06132, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
First Identification of HEV Subtype 3i in Human Hepatitis E Cases in Central Italy.
Journal: Viruses
Published: May 08, 2026
The SIS NET ICU study: characteristics of patients with severe community acquired pneumonia admitted to Italian ICUs-a multicenter prospective observational study.
Journal: Journal of anesthesia, analgesia and critical care
Published: November 25, 2025
Evaluation of a digital remote extraction analysis and monitoring tool for key performance indicators (KPIs) in the blood culture process.
Journal: European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology
Published: June 19, 2025
Platelets from COVID-19 Patients Show an Altered Nitric Oxide/Reactive Oxygen Species Production Balance.
Journal: Thrombosis and haemostasis
Published: April 30, 2025
Case of Fatal Hepatitis Related to HEV-3 Infection in Central Italy.
Journal: Viruses
Published: November 07, 2024
Circulation and Seasonality of Respiratory Viruses in Hospitalized Patients during Five Consecutive Years (2019-2023) in Perugia, Italy.
Journal: Viruses
Published: July 31, 2024
SARS-CoV-2 Molecular Evolution: A Focus on Omicron Variants in Umbria, Italy.
Journal: Microorganisms
Published: June 03, 2024
HEV-3 subtypes and strains detected in cases of HEV infection in central Italy from 2015 to 2023.
Journal: Infection
Published: May 02, 2024
SARS-CoV-2 in semen: a multicenter prospective study and literature review.
Journal: Basic and clinical andrology
Published: February 28, 2024
Case report: Coxiella burnetii endocarditis in the absence of evident exposure.
Journal: Frontiers in medicine
Published: May 10, 2023
Monitoring of indoor bioaerosol for the detection of SARS-CoV-2 in different hospital settings.
Journal: Frontiers in public health
Published: February 18, 2023
Impaired neutralizing antibody efficacy of tixagevimab-cilgavimab 150+150 mg as pre-exposure prophylaxis against Omicron BA.5. A real-world experience in booster vaccinated immunocompromised patients.
Journal: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology
Published: February 07, 2023
Last Updated: 09/26/2026